ACHE and Alzheimer disease: Huprine X (HX), a reversible AChE inhibitor hybrid of tacrine and huperzine A, affects the amyloidogenic process in vitro and the AD-related neuropathology in vivo in mice models of AD [34,35,36,37,38,39,40,41,42].